• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Effectiveness of stand-alone telephone-delivered intervention for reducing problem alcohol use

byMichael WongandAlex Chan
September 26, 2022
in Chronic Disease, Psychiatry
Reading Time: 3 mins read
Factors contributing to parents providing alcohol sips to adolescents
Share on FacebookShare on Twitter

1. In this randomized controlled trial, in participants with problem alcohol use, individuals in the active control group, receiving brief check-ins, and the intervention group, receiving telehealth cognitive and behavioural interventions, both experienced a significant decrease in alcohol use severity 3 months after randomization.  

2. The intervention group showed a significantly greater reduction in alcohol use than the active control group.

Evidence Rating Level: 1 (Excellent)

Alcohol use is a leading cause of preventable morbidity and mortality, but there is a sharp contrast between its prevalence and the use of alcohol treatments. This treatment gap is attributable to the multiple individual and structural barriers that exist, and especially since the pandemic, access to treatment has been further disrupted. Telehealth has the potential to overcome many of the barriers to accessing treatment and has been previously studied in smoking cessation with great success. There is a lack of high-quality evidence surrounding telehealth in the treatment of alcohol use disorders, and the purpose of this single-site, double-blind, parallel-group randomized controlled trial was to examine the effectiveness of a telephone-delivered treatment, Ready2Change, in reducing alcohol use in patients with alcohol use problems. Participants 18 years or older with problem alcohol use (as per the Alcohol Use Disorders Identification Test (AUDIT) score), were recruited from Australia using social media between May 2018 and October 2019. Participants were randomized in a 1:1 ratio to the intervention group or control group. The intervention group received 4-6 sessions of telephone-delivered intervention, while the active control group received 4 telephone check-ins from a researcher. The primary outcome was a change in alcohol problem severity at 3 months after baseline, using the AUDIT score. 344 participants were included in the study, with 173 patients (50.3%) assigned to the intervention group, and 171 participants (49.7%) assigned to the active control group. With respect to the primary outcome, there was a significant difference in the AUDIT score for the treatment group when compared to the active control group at 3 months (difference, -2.15; 95% CI, -3.64 to -0.65; P=.005). There were no significant treatment-by-time interactions observed between the two groups. In both groups, there was a significant decrease in total AUDIT score from baseline to 3 months (P<.001). A major limitation of this study was that the active control group experienced a significant reduction in alcohol use, which was greater than anticipated; future studies should consider this possibility and adjust their trial accordingly. Overall, the findings from this trial did not suggest the superior effectiveness of the intervention when compared to the active control, as both groups experienced a significant decrease in AUDIT score between baseline and three months. However, the intervention group showed a greater reduction in AUDIT score at 3 months relative to the active control group. The results of this trial support benefits of a telephone-delivered intervention, which may reduce the treatment gap for problem alcohol use in the general population.

Click to read the study in JAMA Psychiatry

Image: PD

RELATED REPORTS

Video mental health care may have clinical advantages versus phone or in-person visits

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: alcohol misuse disorderpsychiatrytelehealth
Previous Post

Tofersen does not improve ALS symptoms in patients with SOD1 mutations

Next Post

Occupational and leisure physical activity may have varying effects on inflammation 

RelatedReports

Chronic Disease

Video mental health care may have clinical advantages versus phone or in-person visits

September 12, 2026
Artificial Intelligence

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

September 9, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Quick Take: Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children
Chronic Disease

Positive psychotherapy may be similarly effective to traditional cognitive behavioural therapy for panic disorder

August 21, 2026
Next Post
Reduced gestational weight gain with lifestyle intervention

Occupational and leisure physical activity may have varying effects on inflammation 

No decrease in infant mortality with maternal micronutrient supplementation in Bangladesh

Study details use of inhaled nitric oxide in extremely premature infants in Japan

#VisualAbstract: Induction chemotherapy with erlotinib does not improve survival in stage III-IV head and neck squamous cell carcinoma

#VisualAbstract: Induction chemotherapy with erlotinib does not improve survival in stage III-IV head and neck squamous cell carcinoma

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Probiotic supplementation is associated with reduced risk of death and necrotizing enterocolitis among preterm infants
  • Artificial intelligence (AI)-triggered rapid response notifications were associated with lower mortality among inpatients
  • Post-traumatic stress disorder is associated with increased risk of mild cognitive impairment and dementia among United States Veterans
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.